Little is known about the effects of short-term caloric restriction (CR) and overfeeding (OF) on glucose homeostasis in healthy lean individuals. In addition, it remains unclear whether the effects of CR and OF are reversed by a complementary feeding period. METHODS: Ten healthy men participated in two cycles of controlled 7-day periods of CR and refeeding (RF; protocol A), and OF and CR (protocol B) at ±60% energy requirement. At baseline, insulin sensitivity (IS) was assessed by euglycemic clamp (M). Before and during each feeding cycle, fasting and oral glucose tolerance test-derived indices were used to estimate glucose tolerance, IS and glucose-stimulated insulin secretion. RESULTS: Clamp tests revealed normal IS at baseline (M-values 9.4 ± 2.1 mg kg À1 min À1 , coefficient of variation (CV) inter 22%). M-values were significantly correlated with indices of IS. In protocol A, CR-induced weight loss (À3.0±0.4 kg) was associated with an increase in fasting IS. Postprandial IS and glucose-stimulated insulin secretion remained unchanged, but glucose tolerance decreased. RF decreased fasting and postprandial IS at increased glucose-stimulated insulin secretion. In protocol B, OF significantly increased the body weight ( þ 1.6±0.9 kg). Concomitantly, fasting and postprandial IS decreased at increased glucose-stimulated insulin secretion. Subsequent CR reversed these effects. Inter-individual variability in indices of glucose metabolism was high with coefficients of variation ranging from 9 to 59%. CONCLUSION: Significant changes in glucose metabolism are evident within 7-day periods of controlled OF and underfeeding. Although IS was impaired at the end of the CR --RF cycle, IS was normalized after the OF --CR cycle. At different feeding regimens, homeostatic responses of glucose metabolism were highly variable.
INTRODUCTION
Long-term perturbations in energy balance, either by overfeeding (OF) or underfeeding, are known to modulate insulin sensitivity (IS). Chronic OF and obesity are commonly characterized by insulin resistance, 1 which has been shown to be completely 2 or partially reversed by acute caloric restriction (CR), as well as by moderate weight loss. 3 --5 On the other hand, IS is preserved or even improved with chronic CR in patients with anorexia nervosa and returned to normal values at the end of refeeding (RF). 6 Although considerable research has been devoted to individuals outside the normal range of body weight, there are only few studies examining the effects of short-term controlled perturbations in energy balance on IS in lean subjects without confounding metabolic abnormalities. 7 --17 Moreover, these studies provide discordant findings that may depend on duration and degree of energy imbalance and macronutrient composition of the diets. Fasting (1 --3 days) consistently caused a decline in IS assessed by clamp-and intravenous glucose tolerance test. 7, 8, 17 Studies with less severe CR, however, provided rather inconsistent results. Although some studies have found an impairment of IS within 1 --5 days of CR (p50% energy) in healthy lean subjects, 10, 11 clamp-derived IS has been shown to be sustained following 7 days of CR at an energy intake of 60 kJ kg À1 body weight per day. 9 By contrast, long-term CR has been shown to improve fasting and oral glucose tolerance test (OGTT)-derived indices of IS. 18 Similarly, the effects of short-term OF on IS remain unclear. In lean men, clamp-derived IS remained unchanged following 3 days OF at þ 50% energy, 13 whereas an increase in body mass index by two units has been shown to impair IS in the fasting state, in response to oral and intravenous glucose load, as well as during an euglycemic glucose clamp protocol.
14 A more recent study on lean men has shown that 5 days of high-fat OF at þ 50% energy needs induced a decline in hepatic IS as assessed by clamp, which was compensated by increased insulin secretion. 12 As insulin secretion may compensate for changes in IS in healthy individuals, it is crucial to examine IS in relation to insulin secretion. 1,19 --21 Diet-induced changes in both these measures were found to vary substantially among healthy subjects to maintain normal glucose tolerance. 1, 21 Previous research has tended to focus on either OF or CR, rather than on consecutive periods of OF and CR. However, brief periods of excess or reduced energy intake often succeed one another. Intermittent periods of OF (e.g., holiday weight gain) are often compensated by subsequent self-imposed CR, 22, 23 whereas periods of CR are likely to be followed by excessive energy intake (e.g., yo-yo dieting). 23, 24 Thus, the purpose of the present study was an intra-individual comparison of the effects of consecutive, controlled 1-week periods of altered energy balance (i.e., CR followed by RF, and OF followed by CR) on IS and insulin secretion in a group of healthy lean men.
Specifically, we hypothesized that (i) CR would improve IS at a concomitant decrease in insulin secretion, (ii) whereas OF would impair IS and enhance insulin secretion, and (iii) the effects of CR and OF would be reversed by a complementary feeding period.
SUBJECTS AND METHODS Subjects
Ten healthy, weight-stable men aged 23 --29 years were recruited by notice board postings from the University of Kiel campus. Health status was assessed by medical history and physical examination. Except for one male, whose body mass index was 26.5 kg m À2 , all subjects were of normal weight. Exclusion criteria were smoking, a family history of type 2 diabetes, a history of dieting, and use of any drugs known to affect energy expenditure, glucose tolerance, IS, or insulin secretion. Competitive athletes were also excluded from the study. The study protocol was approved by the local ethical committee of the ChristianAlbrechts-University Kiel. Written informed consent was obtained from all subjects.
Study protocol
The study was performed under free-living metabolic ward conditions. Each subject served as his own control and completed two study protocols (3 weeks each) separated by a 1-week off-protocol episode. Both protocols started with a run-in period followed by CR and RF in protocol A, and by OF and CR in protocol B. Participants arrived at the metabolic ward of the Institute of Human Nutrition and Food Science every morning at 0730 h after an overnight fast of X8 h. During run-in periods, they were allowed to leave the institute after all measurements were completed. During subsequent feeding periods, subjects were requested to stay in the institute until dinner. An outline of the experimental protocol is shown in Figure 1a .
Diet
During run-in periods, ad libitum food intake was allowed and assessed by 7-day food records. During CR, daily energy intake was reduced by 60% of energy requirements (mean energy intake: 4.48 ± 0.32 MJ), whereas it was increased by 60% during RF and OF (mean energy intake: 17.90 ± 1.30 MJ). Individual energy requirement was calculated by multiplying resting energy expenditure (REE) by a factor of 1.4 for physical activity level corresponding to a sedentary physical activity level during the entire study duration. REE was assessed daily during run-in periods by indirect calorimetry (see below). A physical activity level of 1.4 was maintained by limiting physical activity to 5000 steps per day throughout the entire study. This was controlled by wearing activity monitors (SenseWear Pro3 Armband, Body-Media Inc., Pittsburgh, PA, USA). During CR, RF and OF, all food was provided. Individual diets, comprising 45% carbohydrate, 35% fat and 20% protein, were calculated and prepared by an experienced dietitian. Subjects were instructed to eat all food provided, and dietary compliance during the different periods was controlled using continuous glucose monitoring systems (FreeStyle Navigator, Abbott Diabetes Care, Alameda, CA, USA). In addition, meal intake was supervised by a skilled nutritionist. Subjects were allowed to drink water, decaffeinated coffee and tea ad libitum, and fluid intake was recorded.
Anthropometric measurements and body composition analysis
Body weight was measured to the nearest 0.1 kg on an electronic scale, and height was measured to the nearest 0.5 cm, using a stadiometer. Waist circumference was measured to the nearest 0.5 cm, midway between the lowest rib and the iliac crest while the subject was at the end of a normal expiration. Fat mass was assessed either by air-displacement plethysmography (BOD-POD Body Composition System, Life Measurement Instruments, Concord, CA, USA; n ¼ 4) or by hydrodensitometry (Borngässer Waagenbau, Grebbin, Germany; n ¼ 6) as described previously. 25, 26 In a previous study, we had demonstrated a strong agreement between both methods in healthy young men (r ¼ 0.93). 26 calculated as the difference between body weight and fat mass. Liver fat was determined by MRI (Magnetom Vision 1.5-T, Siemens, Erlangen, Germany) along with the Dixon method using ImageJ software (US NIH, Bethesda, MD, USA). 27 The quantity of liver fat was determined as percentage of the total liver core.
Energy expenditure and substrate oxidation
Respiratory exchange measurements were performed by means of an open-circuit indirect calorimeter (ventilated hood system Vmax 29n, SensorMedics, Sensor Medics GmbH, Hö chberg, Germany) as previously described. 28 Oxygen consumption and carbon dioxide production were continuously measured for X30 min, and REE was calculated from steadystate intervals using a standard formula. 29 Activity energy expenditure was assessed by the SenseWear Pro3 Armband (Body-Media Inc.) that was continuously worn on the subjects' dominant arm. Total energy expenditure was calculated as the sum of REE and activity energy expenditure. Cumulative energy balance during each 7-day period was calculated as follows: S energy intake À total energy expenditure.
Twenty-four hour urine samples were collected in 10-ml HCl 25% throughout the study and analyzed for total urea --nitrogen content by a chemiluminescence method (Chemiluminescent Nitrogen System, Model 703C, Antek Instruments, Houston, TX, USA). Substrate oxidation rates were calculated from respiratory exchange data according to Frayn. 30 Blood sampling and analytical procedures Plasma glucose was measured immediately upon sampling during clamp and OGTT, using a glucose oxidase method (BIOSEN C-Line, EKF-diagnostic, Barleben, Germany). Fasting blood samples were obtained from an antecubital vein at the end of each study period. They were immediately centrifuged at 10 1C and samples were frozen at À40 1C until assayed. Plasma glucose was measured by colorimetric test using a Vitros analyzer (Ortho Clinical Diagnostics, Neckargemü nd, Germany). Serum insulin was determined by electrochemiluminescence immunoassay (Elecsys, Roche Diagnostics, Mannheim, Germany). Serum adiponectin levels were determined by enzyme-linked immunosorbent assay (ELISA E09, Mediagnost, Reutlingen, Germany). Free fatty acids (FFA) were quantified using an enzymatic colorimetric assay (HR series NEFA-HR, Wako Chemicals, Neuss, Germany).
Hyperinsulinemic euglycemic clamp
At baseline, peripheral IS was assessed by the hyperinsulinemiceuglycemic clamp technique according to deFronzo et al, 31 combined with indirect calorimetry as previously described. 32, 33 Steady-state glucose disposal rate was calculated from the mean rate of exogenous glucose infusion during the last 30 min of the clamp, after glucose space correction (M-value (mg kg À1 min À1 )). Steady-state concentrations of serum insulin and plasma glucose (coefficient of variation (CV) 6.0 ± 3.1%) were assayed using the previously described methods. 32 Oral glucose tolerance test A standard 75-g OGTT was performed once during each run-in period and at the end of each OF and underfeeding period, with blood sampling for glucose and insulin determinations at 0, 30, 60, 90, 120 and 180 min. Subjects lay quietly in a semi-recumbent position while watching video movies throughout the test. Glucose and insulin responses were calculated as total, as well as incremental area under the curve (AUC), using the trapezoidal method. 34 
Continuous glucose monitoring
Interstitial glucose concentrations were measured by means of the FreeStyle Navigator continuous glucose-monitoring device (Abbott Diabetes Care). A glucose --oxidase-based sensor was applied to the back of the upper arm to measure extracellular fluid glucose in subcutaneous tissue. Sensor readings were reported every 10 min. The sensor was replaced every 5 days, and the device was calibrated on the basis of five capillary blood samples collected during this period. Total AUC for night time (midnight --0700 h) and incremental AUC for day time (0900 --2200 h) glucose were calculated using the trapezoidal method. 34 
Parameters of IS, insulin secretion and glucose tolerance
To estimate IS, insulin secretion and glucose tolerance, previously validated indices from either fasting-or OGTT-derived glucose and insulin concentrations were calculated. 35 
38
Overall glucose-stimulated insulin secretion during OGTT was calculated as AUC-I/AUC-G. 39 AUC-G has been shown to be a good physiological measure of glucose tolerance during OGTT. 40 
Statistical analyses
Statistical analyses were performed in SPSS 15.0. (SPSS Inc., Chicago, IL, USA), and in R 2.11.1 for Windows. As all data are normally distributed (Kolmogorov --Smirnov test), results are given as means ± s.d. A one-way repeated measures analysis of variance was used to examine differences across the periods. If the assumption of sphericity was violated, as examined by Mauchly's test, Greenhouse --Geisser (e p0.75)-or Huynh --Feldt (e 40.75)-adjusted values were used to evaluate significance in the main analysis. When appropriate, Bonferroni post hoc tests were performed, Student's paired t-tests were conducted to compare variables between run-in periods. The relationship between IS and insulin secretion was examined using linear regression analysis after values were natural log-transformed (ln(y) ¼ Àb Â ln(x) þ c). Pearson's correlation was performed to examine the relationship between two variables. Differences were considered statistically significant if Po0.05.
RESULTS

Subject characteristics at baseline
Subjects' baseline anthropometrics, body composition and clamp data are shown in Table 1 . All participants had normal body fat and liver fat at the beginning of the study, except for the one overweight subject who had high body fat (28%), whereas liver fat was normal (3% Body composition, energy balance and substrate utilization throughout the study Cumulative body weight changes over the 7-day periods are shown in Figure 1b . In protocol A, CR resulted in a À3.0 ± 0.4 kg weight loss (Po0.001), with subjects returning to their baseline body weight at the end of subsequent RF ( þ 3.1±1.0 kg, Po0.001). These weight changes were accompanied by a 2.2 ± 1.5 kg decrease in fat mass (Po0.01), with values approximating baseline values following RF ( þ 1.4±1.2 kg, Po0.05).
In protocol B, a 1.6±0.9 kg weight gain (Po0.01) was followed by a À3.4 ± 0.8 kg decrease in body weight (Po0.001). Fat mass tended to increase with weight gain, but only fat mass loss with CR following OF reached statistical significance (À1.9±1.9 kg, Po0.05).
When compared with the run-in values, urinary nitrogen excretion did not change with CR (protocol A 2 g per day) . In contrast, nitrogen excretion was significantly elevated with RF and OF, respectively (RF þ 124%, Po0.001 and OF þ 70%, Po0.01). REE did not significantly change throughout the study (protocol A: run-in 7.8±0.9 MJ per day, CR 7.5 ± 0.7 MJ per day, RF 7.6 ± 0.7 MJ per day; protocol B: run-in 7.6 ± 0.8 MJ per day, OF 7.8 ± 0.8 MJ per day, CR 7.6 ± 0.7 MJ per day). Total energy expenditure decreased during both CR periods (CR A À1.3±1.2 MJ per day, CR B À1.3±1.3 MJ per day vs OF, both Po0.05). Activity energy expenditure significantly decreased with CR A (À0.9 ± 1.1 MJ per day, Po0.05) and tended to decline with CR B (À1.0±1.2 MJ per day, P ¼ 0.08 vs OF). Cumulative energy balance did not differ between the two CR periods (À38.6 ± 5.1 MJ vs À40.2 ± 12.1 MJ), and between RF and OF (54.1 ± 9.3 MJ vs 52.5 ± 14.6 MJ), respectively (all Po0.001).
Parameters of glucose metabolism and IS Absolute values as well as relative changes in parameters of glucose metabolism in protocol A and B can be seen in Tables 2   and 3 . The total (AUC t ) and incremental AUC (AUC i ) for glucose and insulin concentrations during the OGTT were highly correlated (AUC-G t vs AUC-G i , r ¼ 0.91; AUC-I t vs AUC-I i , r ¼ 0.99; AUC-G t /AUC-I t vs AUC-G i /AUC-I i , r ¼ 0.72, all Po0.001).
Protocol A. CR significantly decreased fasting insulin and glucose concentrations (À47%, Po0.01 and À10%, Po0.05), and consequently increased fasting IS (HOMA-IR À51%, Po0.001). Following an oral glucose load, hyperglycemia and hyperinsulinemia were seen (AUC-G t þ 31% and AUC-I t þ 34%, both Po0.05), but postprandial IS (ISI-Matsuda) and glucose-stimulated insulin secretion (AUC-I t /AUC-G t ) remained unchanged. CR had no effect on serum adiponectin levels, but serum FFA increased with CR (Po0.05).
Subsequent RF significantly increased basal levels of glucose and insulin, when compared with CR ( þ 9%, Po0.05 and þ 123%, Po0.01). After the oral glucose load, hyperinsulinemia persisted (AUC-I t þ 12% vs CR, NS; þ 50% vs run-in, Po0.01), whereas AUC-G t tended to decrease (À14%, P ¼ 0.12 vs CR) and did not differ from run-in values. Postprandial IS decreased with RF (ISI-Matsuda À48%, Po0.05 vs CR) at increased glucose-stimulated insulin secretion (AUC-I t /AUC-G t þ 33%, Po0.05 vs CR).
A positive but non-significant correlation was found between total AUC-G calculated from OGTT and incremental daytime AUC-G calculated from continuous glucose monitoring at the end of RF (r ¼ 0.66, P ¼ 0.07). Compared with CR, RF increased serum adiponectin levels (Po0.001), but decreased serum FFA (Po0.01).
Protocol B. OF increased fasting insulin levels ( þ 98%, Po0.01) and decreased fasting IS (HOMA-IR þ 99%, Po0.01). Fasting glucose levels remained unchanged. Following an oral glucose load, AUC-I t increased ( þ 46%, Po0.01), whereas AUC-G t remained unchanged. ISI-Matsuda indicated reduced postprandial IS following OF (À33%, Po0.01). Glucose-stimulated insulin Table 2 . Glucose tolerance, insulin sensitivity and insulin secretion at the end of each 7-day study period (n ¼ 10) secretion was significantly increased with OF (AUC-I t /AUC-G t þ 36%, Po0.01). There was no effect of OF on serum adiponectin levels. Serum FFA decreased with OF (Po0.05). Subsequent CR decreased basal levels of glucose and insulin (À8 and À61%, both Po0.01 vs OF), and consequently increased fasting IS (HOMA-IR À64%, Po0.01 vs OF). When compared with OF, AUC-I t decreased (À30%, Po0.01) at unchanged AUC-G t . Concomitantly, postprandial IS improved (ISI-Matsuda þ 168%, Po0.01 vs OF), and glucose-stimulated insulin secretion significantly declined with CR to approximate run-in values (AUC-I t / AUC-G t À33%, Po0.01 vs OF).
A positive correlation was found between total AUC-G calculated from OGTT and incremental daytime AUC-G measured by continuous glucose monitoring at the end of OF (r ¼ 0.93, Po0.01). Compared with OF, CR decreased serum adiponectin levels, but increased serum FFA (both Po0.05).
Relationship between IS and insulin secretion Using all data obtained during different feeding regimens, there was a non-linear inverse relationship between postprandial IS and glucose-stimulated insulin secretion (r ¼ À0.66, Po0.001; Figure 2 ). Plotting individual courses of IS versus insulin secretion during changes in energy balance (i.e., at different feeding regimens), individual glucose homeostasis was visualized as an area. This area was quantified by calculating the area inside the complex hull, which is considered the most objective approach. Moreover, the area was characterized by its diameter (i.e., the greatest distance between any pair of vertices). Diameter, but not area, tended to be negatively correlated with baseline HOMA-IR (r ¼ À0.61, P ¼ 0.06). No significant correlation could be found between area and diameter, and M-value, serum insulin, body weight, %FM, REE, and body weight changes. Variance in postprandial glucose metabolism Inter-and intra-individual variability in indices of glucose metabolism expressed as CV can be seen in Table 4 . During each study period, a high inter-individual variability in IS, insulin secretion and glucose tolerance was observed with mean CVs ranging from 9 to 52%. When comparing both run-in, CR and OF periods, respectively, mean intra-individual CVs ranged from 6 to 31%. Intra-individual variability in OGTT-derived indices was highest in run-in periods and decreased with controlled feeding. In addition, a high variability was found when comparing area and diameter derived from the individual IS versus insulin secretion relationship over the whole study period between subjects (area range 6.9 --39.7 (unit of area), CV inter 59%; diameter range 7.4 --32.9 (unit of area) CV inter 57%; Figure 2 ).
DISCUSSION
The present study describes how short-term perturbations in energy balance affect fasting and OGTT-derived indices of IS, insulin secretion and glucose tolerance. The study was performed in healthy, normal weight subjects with normal liver fat and normal IS as assessed by the hyperinsulinemic-euglycemic clamp. Our data show that IS was impaired at the end of the CR --RF cycle, whereas it was normalized after the OF --CR cycle. Changes in postprandial glucose metabolism in response to short-term perturbations in energy balance were found to vary substantially between individuals. For each parameter of glucose metabolism, the intra-individual variability was lower than the corresponding inter-individual variability.
Effect of 1-week CR Our study demonstrated that 1-week CR (À60% energy) resulted in an increased fasting IS, whereas postprandial IS and insulin secretion were unaltered. Concomitantly, glucose tolerance decreased. ISI-Matsuda remained unchanged, possibly due to the combination of fasting and glucose-stimulated values in the calculation of the index. As fasting glucose and insulin significantly decreased in the present study, whereas AUC-G and AUC-I increased postprandially, the composite ISI-Matsuda is likely to be unaltered. 17 However, AUC-I and AUC-G tended to rise in parallel, thus indicating a decrease in postload IS. Starvation has consistently been shown to decrease IS and deteriorate postprandial glucose tolerance. 7, 8, 17 Similarly, further studies have demonstrated a decline in clamp-derived IS within 24 h (200 kcal per day) and 5 days (À50% energy) of CR, respectively. 10, 11 Severe carbohydrate restriction induces postprandial hyperglycemia and IR at skeletal muscle to shift fuel to the brain. 41 As to the mechanisms, increased FFA availability through increased lipolysis (Table 2 and 3), together with endocrine alterations (e.g., elevated growth hormone levels) and stress-response 42 add to impair IS. We could, however, not confirm CR-induced stress in our subjects, as examined by heart-rate monitoring (data not shown) and REE (results). On the other hand, Gallen et al. 9 found a sustained IS following 6 days of CR at an energy intake of 60 kJ kg À1 body weight. However, in that study, no information is given about the macronutrient composition of the diet. Thus, it can be speculated about the carbohydrate content of that diet. In contrast to shortterm CR, adequate carbohydrate intake and less stressful, moderate long-term CR has previously been shown to improve IS. For example, 12 months of moderate CR (À20% energy) improved fasting and OGTT-derived indices of IS. 18 As in our study, a sustained insulin secretion with CR has also been found by other studies to prevent unfavorable protein catabolism. 43 Effect of 1-week OF Fasting and postprandial IS were significantly impaired after 1-week OF ( þ 60% energy). Concomitantly, postprandial insulin secretion increased. Likewise, previous studies have found a consistent decrease in IS in response to short-term OF (X7 days) in healthy lean subjects, as assessed by hyperinsulinemic euglycemic clamp, 14, 15 and by oral or intravenous glucose tolerance test. 14, 16 In these studies, including OF up to 14 days, mean weight change varied between 0.3 and 3.0 kg, 12, 15, 16 which is similar to the 1.6 kg weight gain in our subjects (Figure 1b) . The observed decrease in IS with OF might be due to metabolic effects of increased energy and macronutrient intake per se, as well as to alterations in body composition (i.e., an accumulation of ectopic fat). 44, 45 By contrast, previous studies in lean, healthy men have reported a selective decline in hepatic IS or even a completely sustained IS, as assessed by hyperinsulinemic euglycemic clamp. 12, 13 Owing to the shorter study duration (o6 days), no significant weight changes occurred. A reduction in glycogen Table 4 . Inter-and intra-individual variability in parameters of glucose metabolism during the different study periods (n ¼ 10) storage capacity, for example, was evident following 2 weeks OF with an energy intake of þ 62%. 15 Brons et al. 12 showed that intravenous tolerance test-derived increases in insulin secretion compensate for hepatic IR and precede peripheral IR within 5 days OF, thus indicating temporal differences in glucose metabolism. Likewise, we did also find an increase in glucosestimulated insulin secretion following 7 days of OF.
Effect of complementary feeding Although mean body weight returned to run-in values and thus energy balance was assumed to be restored at the end of the CR --RF cycle (±60% energy), postprandial IS remained decreased. Glucose-stimulated insulin secretion was compensatorily increased. In protocol A, calculated energy balance exceeded run-in values by 15.5 MJ following RF. The decrease in postprandial IS might therefore be due to the positive energy balance per se. 45 Contrary to the CR --RF cycle, CR following OF compensated for the impaired IS with all parameters of IS being normalized. The latter finding is consistent with the sustained IS that has been found in normal weight women with bulimia nervosa, engaging in intermittent 'binge-purge cycles'. 46 In addition, CR has been shown to significantly improve IS in previously obese, diabetic subjects. 2, 47 Coming from a pathological state of IR, which might be comparable to the acute OF in the present study, CR thus seems to have favorable effects on glucose metabolism.
Characterization of glucose homeostasis during different, controlled feeding regimens A hyperbolic relationship between IS and glucose-induced insulin secretion has been affirmed in healthy individuals by intravenous glucose testing, 20 as well as OGTT-derived parameters. 39, 48 It aims to defend normal glucose tolerance. 1 As in the present study, the combination of ISI-Matsuda with AUC-I/AUC-G ratio has been shown to achieve the best adjustment to a hyperbolic curve in a cross-sectional study in normoglycemic women 39 ( Figure 2 ). The hyperbola describes the normal physiological response of the pancreatic b-cells to compensate alterations in IS. 1,19 --21 Similar to Maki et al., 48 we could not confirm a true hyperbolic relationship (95% confidence interval of the slope À0.55 to À0.30). This might be due, for example, to the regression method used, assuming the independent variable as error free, thus possibly underestimating R 2 . 48, 49 Our data show that each subject followed an individual response to different feeding conditions (Figure 2 ). The intra-individual variations in the dynamic IS versus insulin secretion relationship can be illustrated by individual areas and its diameters to characterize the shape of the association. Both of these variables show a wide between-subject variability and partly deviate from the shape of the hyperbola (Figure 2 ). We consider this as an alternative approach to characterize IS and insulin secretion under real-life feeding conditions, which adds further aspects to individual phenotyping of glucose homeostasis, that is, adding the dynamic responses of glucose metabolism to nutrition.
Variance in glucose homeostasis Feeding-induced changes in glucose homeostasis show a high inter-and intra-individual variance. Despite (i) a homogenous study population of lean, young, healthy subjects, and (ii) a tightly controlled study protocol, there was a wide inter-and intraindividual variability in glucose metabolism over the course of the study (Table 4 ). The majority of intra-individual variability was explained by biological variance, with methodological variability accounting for less than 10% (data not shown). The considerably large inter-individual variability in indices of glucose metabolism might be explained by phenotypic differences between the individuals, as well as by the pronounced non-steady state conditions observed during 7-day periods OF and underfeeding. Therefore, to reduce between subject variability, it might be necessary to conduct studies with prolonged periods of OF and underfeeding in which a new steady state is approached.
Study limitations
Our study is descriptive, and findings are based on indirect indices of glucose homeostasis and therefore need to be interpreted cautiously. For example, it is unclear whether the underlying assumptions of the HOMA index are fulfilled during CR, OF and RF. However, HOMA-IR and OGTT-derived indices, such as ISI-Matsuda, have been shown to be significantly related to clamp-derived M-values (Results). 35, 36, 38 Incremental AUC might be a more accurate parameter to describe glycemic response to food, but total AUC has been shown to be a useful physiological measure of insulin-mediated glucose uptake. 40 Comparing total with incremental AUC of glucose and insulin, both variables were highly correlated (Results). Differences were observed between the run-in phases of protocol A and B for a number of parameters (i.e., serum concentrations of adiponectin and fasting insulin, HOMA-IR; Table 2 ). This might be explained by the short duration of the off-protocol episode between the study protocols (i.e., 1 week), so that carry-over effects cannot be excluded. In addition, ad libitum dietary intake was highly variable within run-in periods (CV 26.8%), but mean data did not differ between run-in A and B (9.16 ± 2.22 MJ per day vs 9.38 ± 1.75 MJ per day). However, minor day-to-day variations in energy balance cannot be excluded, although body weight remained fairly constant within each run-in period (CV run-in A 0.5%, CV run-in B 0.6%). Intra-individual comparisons, however, compensated for differences in baseline values. As physical activity was restricted to 5000 steps per day, a simultaneous effect of detraining on changes in glucose metabolism cannot be ruled out. However, to minimize bias associated with detraining, athletes were excluded from participation. Moreover, subjects were instructed not to perform heavy bouts of exercise before the study protocols.
In conclusion, the present study showed that significant changes in glucose metabolism, as assessed by fasting and OGTT-derived indices, are already evident within 7 days of controlled OF and underfeeding in a group of healthy lean subjects. CR led to an increase in fasting IS, whereas postprandial IS and glucose-stimulated insulin secretion remained unchanged. OF decreased fasting and postprandial IS at increased glucosestimulated insulin secretion. A CR --RF cycle led to an impairment of IS, whereas IS was restored following an OF --CR cycle.
